Runge VM - Search Results

1

T1 relaxivities of gadolinium-based magnetic resonance contrast agents in human whole blood at 1.5, 3, and 7 T.

Shen Y, Goerner FL, Snyder C, Morelli JN, Hao D, Hu D, Li X, Runge VM. Shen Y, et al. Among authors: runge vm. Invest Radiol. 2015 May;50(5):330-8. doi: 10.1097/RLI.0000000000000132. Invest Radiol. 2015. PMID: 25658049 Free article.

2

Efficacy of gadoteridol for magnetic resonance imaging of the brain and spine.

Runge VM, Bronen RA, Davis KR. Runge VM, et al. Invest Radiol. 1992 Aug;27 Suppl 1:S22-32. Invest Radiol. 1992. PMID: 1506150 Clinical Trial.

3

Clinical safety and efficacy of gadoteridol: a study in 411 patients with suspected intracranial and spinal disease.

Runge VM, Bradley WG, Brant-Zawadzki MN, Carvlin MJ, DeSimone DN, Dean BL, Dillon WP, Drayer BP, Flanders AE, Harms SE, et al. Runge VM, et al. Radiology. 1991 Dec;181(3):701-9. doi: 10.1148/radiology.181.3.1947085. Radiology. 1991. PMID: 1947085 Clinical Trial.

4

Interactions of paramagnetic contrast agents and the spin echo pulse sequence.

Davis PL, Parker DL, Nelson JA, Gillen JS, Runge VM. Davis PL, et al. Among authors: runge vm. Invest Radiol. 1988 May;23(5):381-8. doi: 10.1097/00004424-198805000-00010. Invest Radiol. 1988. PMID: 3384619

5

Contrast enhanced MRI. Evaluation of a canine model of osmotic blood-brain barrier disruption.

Runge VM, Price AC, Wehr CJ, Atkinson JB, Tweedle MF. Runge VM, et al. Invest Radiol. 1985 Nov;20(8):830-44. Invest Radiol. 1985. PMID: 4077437

6

Intravascular contrast agents suitable for magnetic resonance imaging.

Runge VM, Clanton JA, Herzer WA, Gibbs SJ, Price AC, Partain CL, James AE Jr. Runge VM, et al. Radiology. 1984 Oct;153(1):171-6. doi: 10.1148/radiology.153.1.6433402. Radiology. 1984. PMID: 6433402

7

Paramagnetic NMR contrast agents. Development and evaluation.

Runge VM, Clanton JA, Foster MA, Smith FW, Lukehart CM, Jones MM, Partain CL, James AE Jr. Runge VM, et al. Invest Radiol. 1984 Sep-Oct;19(5):408-15. doi: 10.1097/00004424-198409000-00013. Invest Radiol. 1984. PMID: 6439672

8

The use of MR contrast in nonneoplastic disease of the brain.

Runge VM. Runge VM. Top Magn Reson Imaging. 1995 Summer;7(3):158-67. Top Magn Reson Imaging. 1995. PMID: 7654394 Review.

9

Magnetic resonance imaging of an experimental model of intracranial metastatic disease. A study of lesion detectability.

Runge VM, Wells JW, Williams NM. Runge VM, et al. Invest Radiol. 1994 Dec;29(12):1050-6. doi: 10.1097/00004424-199412000-00007. Invest Radiol. 1994. PMID: 7721546

10

Comparison of gadolinium Cy2DOTA, a new hepatobiliary agent, and gadolinium HP-DO3A, an extracellular agent, in healthy liver and metastatic disease.

Runge VM, Wells JW, Williams NM. Runge VM, et al. Invest Radiol. 1995 Feb;30(2):123-30. doi: 10.1097/00004424-199502000-00012. Invest Radiol. 1995. PMID: 7782188

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

236 results

Search Page

Filters